Angela Panoskaltsis-Mortari, PhD is a Professor of Pediatrics in the Division of Blood and Marrow Transplant & Cellular Therapy. She is also a Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine. Dr. Panoskaltsis-Mortari is the Director of the Cytokine Reference Laboratory, the Director of the 3D Bioprinting Facility at the University of Minnesota, Vice Chair for Research for the Department of Pediatrics, and the Assistant Director of the Earl E. Bakken Medical Devices Center.

Dr. Panoskaltsis-Mortari received her PhD from the University of Western Ontario. She was a post-doctoral fellow in the Department of Pathology at the University of Alabama and a post-doctoral research associate in the Department of Pediatrics at the University of Minnesota. She joined the University of Minnesota faculty in 1995.

Panoskaltsis-Mortari has board certification from the American Board of Medical Laboratory Immunology. She is a member of numerous immunology, pulmonary and hematology professional societies, and the author of over 250 articles which have appeared in such publications as Journal of Experimental Medicine, Journal of Clinical Investigation, Blood, Biology of Blood and Marrow Transplantation, American Journal of Physiology (Lung, Cell. & Mol. Physiol.) and Journal of Immunology.

Brenda Ogle, PhD is a Professor of Pediatrics and Biomedical Engineering in the Medical School and College of Science and Engineering at the University of Minnesota. She is the head of the Biomedical Engineering department and the Director of the Stem Cell Institute. Her research is pushing the boundaries of 3D bioprinting for cardiac tissue engineering to create complex model systems that extend well beyond the “wood piles” and simple geometric shapes prevalent in the literature. This work is enabled by basic studies to understand the interplay between the extracellular matrix, pluripotent stem cells and associated cardiac progeny.

Susan Keirstead, PhD is an Assistant Professor of Integrative Biology and Physiology and the Administrative Co-director of the Stem Cell Institute. Her research involves the functional characterization of stem cell-derived cells, including cardiomyocytes and neurons with a view towards understanding normal physiological development of human cell types and pathogenesis of genetic diseases.

Markus Reiterer grow up in Austria and holds a M.S. and Ph.D. from the University of Leoben. Before joining Medtronic in 2006, he worked as postdoc at Sandia Natl. Labs. He is known as expert for finite element analysis, materials science, and medical device innovation and development. Markus has been the President of the Medtronic Technical Forum and is currently the chair of the Technical Fellows organization. He serves on the board of the Avicenna Alliance and represents Medtronic at the Advanced Regenerative Manufacturing Institute (ARMI). He has given multiple invited talks at international conference, published 18 peer-reviewed papers, and holds 12 patents.

Medtronic: www.medtronic.com

LinkedIn: https://www.linkedin.com/in/markus-reiterer-b373b07

Lexi Garcia is the Director of Strategic Projects at the Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA. As such she is responsible for coordinating and leading cross-functional teams to drive key project activities to help shape the long-term vision of the company. She co-leads and supports ARMI | BioFabUSA standard initiatives, particularly those related to bioprinting and due to her previous role as an outreach coordinator and member support manager has a wide network to enable connections between key stakeholders throughout the tissue engineering community to facilitate partnerships that will propel the field forward. With degrees in Neuroscience from Middlebury College, and Conservation Biology and Sustainable Development from the University of Maryland, College Park (UMD) she has a unique systems perspective and approach to nurturing the tissue engineering ecosystem to garner consensus and improve collaborative efforts.

Mary Clare McCorry is the Director for Technology and Process Development at the Advanced Regenerative Manufacturing Institute (ARMI). Prior to joining ARMI, she was an American Institute for Medical and Biological Engineering (AIMBE) Scholar at the U.S. Food and Drug Administration in the Center for Devices and Radiological Health (CDRH). As an AIMBE Scholar, she led science policy initiatives and coordinated collaborations between experts in academia, industry, government and non-profit organizations. Mary Clare joined FDA from Cornell University where she designed cell-based assays to study biomechanical/chemical mechanisms of action of cells in tissue engineered constructs. She also consulted for industry on the design of specialized single use tissue bioreactors. Mary Clare received her PhD from Cornell University and her BS in Biomedical Engineering from Worcester Polytechnic Institute.

Greta Babakhanova is a Physicist at the National Institute of Standards and Technology (NIST). She completed her PhD in Chemical Physics from the Advanced Materials and Liquid Crystal Institute, Kent State University in 2019. There, Greta worked on characterizing twist-bend nematic liquid crystals and developed stimuli-responsive elastomer coatings with pre-determined surface topographies. At NIST, she is working in the Biomaterials group with Carl Simon to develop robust standard protocols for measuring cell viability in three-dimensional scaffolds.